MRK logo

Merck & Co (MRK) Operating profit

annual operating profit:

$20.22B+$17.27B(+584.53%)
December 31, 2024

Summary

  • As of today (April 25, 2025), MRK annual operating income is $20.22 billion, with the most recent change of +$17.27 billion (+584.53%) on December 31, 2024.
  • During the last 3 years, MRK annual operating profit has risen by +$7.02 billion (+53.20%).
  • MRK annual operating profit is now at all-time high.

Performance

MRK Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

quarterly operating profit:

$4.35B+$363.00M(+9.11%)
December 31, 2024

Summary

  • As of today (April 25, 2025), MRK quarterly operating income is $4.35 billion, with the most recent change of +$363.00 million (+9.11%) on December 31, 2024.
  • Over the past year, MRK quarterly operating profit has increased by +$363.00 million (+9.11%).
  • MRK quarterly operating profit is now -29.06% below its all-time high of $6.13 billion, reached on June 30, 2024.

Performance

MRK quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

TTM operating profit:

$20.22B+$6.06B(+42.80%)
December 31, 2024

Summary

  • As of today (April 25, 2025), MRK TTM operating income is $20.22 billion, with the most recent change of +$6.06 billion (+42.80%) on December 31, 2024.
  • Over the past year, MRK TTM operating profit has increased by +$6.06 billion (+42.80%).
  • MRK TTM operating profit is now at all-time high.

Performance

MRK TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

MRK Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+584.5%+9.1%+42.8%
3 y3 years+53.2%+9.1%+42.8%
5 y5 years+155.1%+9.1%+42.8%

MRK Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+584.5%-29.1%+186.7%at high+584.7%
5 y5-yearat high+584.5%-29.1%+186.7%at high+584.7%
alltimeall timeat high+2438.1%-29.1%+186.7%at high+2464.2%

Merck & Co Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$20.22B(+584.5%)
$4.35B(+9.1%)
$20.22B(+42.8%)
Sep 2024
-
$3.98B(-35.0%)
$14.16B(-11.8%)
Jun 2024
-
$6.13B(+6.4%)
$16.05B(+227.0%)
Mar 2024
-
$5.76B(-436.3%)
$4.91B(+66.2%)
Dec 2023
$2.95B(-83.8%)
-$1.71B(-129.2%)
$2.95B(-63.8%)
Sep 2023
-
$5.87B(-217.2%)
$8.15B(+27.6%)
Jun 2023
-
-$5.01B(-231.7%)
$6.39B(-61.2%)
Mar 2023
-
$3.81B(+9.1%)
$16.47B(-9.9%)
Dec 2022
$18.28B(+38.5%)
$3.49B(-15.1%)
$18.28B(-1.4%)
Sep 2022
-
$4.11B(-19.0%)
$18.54B(-4.2%)
Jun 2022
-
$5.07B(-9.9%)
$19.36B(+21.1%)
Mar 2022
-
$5.62B(+50.0%)
$15.99B(+21.2%)
Dec 2021
$13.20B(+137.9%)
$3.75B(-23.8%)
$13.20B(+89.6%)
Sep 2021
-
$4.92B(+190.3%)
$6.96B(+53.2%)
Jun 2021
-
$1.70B(-40.0%)
$4.54B(-14.0%)
Mar 2021
-
$2.83B(-213.7%)
$5.28B(-17.9%)
Dec 2020
$5.55B(-30.0%)
-$2.49B(-199.2%)
$6.44B(-12.7%)
Sep 2020
-
$2.51B(+2.9%)
$7.37B(-1.4%)
Jun 2020
-
$2.44B(-38.8%)
$7.48B(-12.0%)
Mar 2020
-
$3.98B(-356.3%)
$8.50B(+7.2%)
Dec 2019
$7.93B(-11.3%)
-$1.55B(-159.4%)
$7.93B(-35.7%)
Sep 2019
-
$2.61B(-24.4%)
$12.33B(-0.4%)
Jun 2019
-
$3.46B(+1.5%)
$12.38B(+10.7%)
Mar 2019
-
$3.41B(+19.5%)
$11.19B(+25.3%)
Dec 2018
$8.93B(+31.4%)
$2.85B(+7.1%)
$8.93B(+10.1%)
Sep 2018
-
$2.66B(+17.6%)
$8.12B(+45.0%)
Jun 2018
-
$2.27B(+97.2%)
$5.60B(-4.5%)
Mar 2018
-
$1.15B(-43.6%)
$5.86B(-13.7%)
Dec 2017
$6.80B(+23.6%)
$2.04B(+1294.5%)
$6.80B(+80.2%)
Sep 2017
-
$146.00M(-94.2%)
$3.77B(-43.7%)
Jun 2017
-
$2.53B(+21.6%)
$6.70B(+15.0%)
Mar 2017
-
$2.08B(-310.4%)
$5.82B(+5.8%)
Dec 2016
$5.50B(-27.1%)
-$990.00M(-132.2%)
$5.50B(-34.8%)
Sep 2016
-
$3.07B(+85.3%)
$8.44B(+9.5%)
Jun 2016
-
$1.66B(-6.0%)
$7.71B(-1.0%)
Mar 2016
-
$1.76B(-9.7%)
$7.79B(+3.2%)
Dec 2015
$7.55B(+12.9%)
$1.95B(-16.6%)
$7.55B(+6.0%)
Sep 2015
-
$2.34B(+34.7%)
$7.12B(+9.9%)
Jun 2015
-
$1.74B(+14.4%)
$6.48B(+5.4%)
Mar 2015
-
$1.52B(-0.5%)
$6.15B(-8.0%)
Dec 2014
$6.68B(-12.8%)
$1.52B(-10.3%)
$6.68B(-5.3%)
Sep 2014
-
$1.70B(+21.1%)
$7.05B(-9.8%)
Jun 2014
-
$1.40B(-31.6%)
$7.82B(-1.0%)
Mar 2014
-
$2.05B(+8.3%)
$7.90B(+3.1%)
Dec 2013
$7.67B(-22.4%)
$1.90B(-23.1%)
$7.66B(-0.9%)
Sep 2013
-
$2.46B(+66.0%)
$7.73B(+1.2%)
Jun 2013
-
$1.49B(-18.3%)
$7.64B(-14.5%)
Mar 2013
-
$1.82B(-7.4%)
$8.94B(-9.5%)
Dec 2012
$9.88B(+10.0%)
$1.96B(-17.2%)
$9.88B(-0.3%)
Sep 2012
-
$2.37B(-14.9%)
$9.91B(-0.1%)
Jun 2012
-
$2.79B(+1.0%)
$9.91B(+3.4%)
Mar 2012
-
$2.76B(+38.2%)
$9.59B(+6.2%)
Dec 2011
$8.98B(+167.5%)
$2.00B(-16.0%)
$9.03B(+36.9%)
Sep 2011
-
$2.38B(-3.5%)
$6.59B(+17.0%)
Jun 2011
-
$2.46B(+11.9%)
$5.64B(+22.0%)
Mar 2011
-
$2.20B(-598.6%)
$4.62B(+37.7%)
Dec 2010
$3.35B(-16.6%)
-$441.00M(-131.1%)
$3.35B(-5.8%)
Sep 2010
-
$1.42B(-1.6%)
$3.56B(-5.8%)
Jun 2010
-
$1.44B(+54.7%)
$3.78B(+0.6%)
Mar 2010
-
$933.00M(-498.2%)
$3.76B(-6.5%)
Dec 2009
$4.02B(-33.9%)
-$234.30M(-114.3%)
$4.02B(-27.8%)
Sep 2009
-
$1.64B(+15.4%)
$5.57B(+1.4%)
Jun 2009
-
$1.42B(+19.0%)
$5.49B(-2.4%)
Mar 2009
-
$1.19B(-9.1%)
$5.63B(-7.5%)
Dec 2008
$6.08B(+8.3%)
$1.31B(-16.1%)
$6.08B(-4.5%)
Sep 2008
-
$1.56B(+0.6%)
$6.37B(+6.7%)
Jun 2008
-
$1.56B(-5.8%)
$5.97B(+1.9%)
Mar 2008
-
$1.65B(+3.4%)
$5.86B(+4.3%)
Dec 2007
$5.62B(+52.4%)
$1.60B(+37.1%)
$5.62B(+29.8%)
Sep 2007
-
$1.16B(-19.4%)
$4.33B(+16.5%)
Jun 2007
-
$1.44B(+2.4%)
$3.71B(+0.7%)
Mar 2007
-
$1.41B(+361.0%)
$3.69B(+0.0%)
Dec 2006
$3.69B(-37.1%)
$306.20M(-44.4%)
$3.69B(-18.3%)
Sep 2006
-
$550.30M(-61.2%)
$4.51B(-17.3%)
Jun 2006
-
$1.42B(+0.7%)
$5.45B(-3.3%)
Mar 2006
-
$1.41B(+24.8%)
$5.64B(-3.9%)
Dec 2005
$5.86B(-13.3%)
$1.13B(-24.4%)
$5.87B(+0.1%)
Sep 2005
-
$1.49B(-6.9%)
$5.86B(-0.1%)
Jun 2005
-
$1.60B(-2.1%)
$5.87B(-10.0%)
Mar 2005
-
$1.64B(+45.6%)
$6.52B(-3.5%)
Dec 2004
$6.76B
$1.13B(-25.0%)
$6.76B(-9.8%)
Sep 2004
-
$1.50B(-33.4%)
$7.49B(-11.1%)
DateAnnualQuarterlyTTM
Jun 2004
-
$2.26B(+20.3%)
$8.43B(+1.6%)
Mar 2004
-
$1.87B(+0.8%)
$8.30B(-3.0%)
Dec 2003
$8.57B(-5.7%)
$1.86B(-23.7%)
$8.56B(-7.2%)
Sep 2003
-
$2.44B(+14.8%)
$9.22B(+1.1%)
Jun 2003
-
$2.12B(-0.5%)
$9.12B(-2.5%)
Mar 2003
-
$2.14B(-15.4%)
$9.35B(-0.1%)
Dec 2002
$9.09B(-2.0%)
$2.52B(+7.9%)
$9.36B(+4.6%)
Sep 2002
-
$2.34B(-0.8%)
$8.95B(-3.2%)
Jun 2002
-
$2.36B(+10.0%)
$9.24B(-0.1%)
Mar 2002
-
$2.14B(+1.6%)
$9.26B(-0.2%)
Dec 2001
$9.28B(+2.1%)
$2.11B(-20.1%)
$9.28B(-2.8%)
Sep 2001
-
$2.64B(+11.4%)
$9.55B(+2.4%)
Jun 2001
-
$2.37B(+9.4%)
$9.32B(+0.7%)
Mar 2001
-
$2.16B(-9.0%)
$9.26B(+1.8%)
Dec 2000
$9.09B(+19.7%)
$2.38B(-1.3%)
$9.09B(+4.1%)
Sep 2000
-
$2.41B(+4.9%)
$8.73B(+5.4%)
Jun 2000
-
$2.30B(+15.1%)
$8.29B(+5.0%)
Mar 2000
-
$2.00B(-1.3%)
$7.89B(+3.9%)
Dec 1999
$7.59B(+19.1%)
$2.02B(+3.1%)
$7.59B(+3.4%)
Sep 1999
-
$1.96B(+3.2%)
$7.34B(+4.1%)
Jun 1999
-
$1.90B(+11.7%)
$7.05B(+5.4%)
Mar 1999
-
$1.70B(-4.0%)
$6.69B(+4.9%)
Dec 1998
$6.38B(+8.7%)
$1.77B(+6.1%)
$6.38B(+1.7%)
Sep 1998
-
$1.67B(+8.7%)
$6.27B(+4.3%)
Jun 1998
-
$1.54B(+10.6%)
$6.01B(+1.1%)
Mar 1998
-
$1.39B(-16.6%)
$5.95B(+1.5%)
Dec 1997
$5.86B(+17.6%)
$1.67B(+17.9%)
$5.86B(+6.4%)
Sep 1997
-
$1.42B(-4.1%)
$5.51B(+2.2%)
Jun 1997
-
$1.48B(+13.1%)
$5.39B(+3.7%)
Mar 1997
-
$1.30B(-1.0%)
$5.20B(+4.4%)
Dec 1996
$4.98B(+13.2%)
$1.32B(+1.7%)
$4.98B(+4.8%)
Sep 1996
-
$1.30B(+1.0%)
$4.76B(+2.8%)
Jun 1996
-
$1.28B(+18.2%)
$4.63B(+2.7%)
Mar 1996
-
$1.09B(-0.3%)
$4.51B(+2.3%)
Dec 1995
$4.40B(-0.0%)
$1.09B(-6.5%)
$4.40B(+1.1%)
Sep 1995
-
$1.17B(+0.2%)
$4.36B(-0.0%)
Jun 1995
-
$1.16B(+18.1%)
$4.36B(-0.9%)
Mar 1995
-
$985.10M(-5.6%)
$4.40B(-0.2%)
Dec 1994
$4.41B(+13.4%)
$1.04B(-10.5%)
$4.41B(-14.3%)
Sep 1994
-
$1.17B(-3.0%)
$5.14B(+3.2%)
Jun 1994
-
$1.20B(+21.0%)
$4.98B(+24.8%)
Mar 1994
-
$993.20M(-44.1%)
$3.99B(+2.6%)
Dec 1993
$3.89B(+11.3%)
$1.78B(+76.5%)
$3.89B(+32.0%)
Sep 1993
-
$1.01B(+373.8%)
$2.94B(+4.0%)
Jun 1993
-
$212.40M(-76.1%)
$2.83B(-20.3%)
Mar 1993
-
$890.30M(+6.7%)
$3.55B(+1.7%)
Dec 1992
$3.49B(+12.3%)
$834.40M(-6.5%)
$3.49B(+1.4%)
Sep 1992
-
$892.80M(-4.2%)
$3.44B(+3.1%)
Jun 1992
-
$931.70M(+11.9%)
$3.34B(+3.6%)
Mar 1992
-
$832.60M(+6.1%)
$3.22B(+3.6%)
Dec 1991
$3.11B(+17.3%)
$784.50M(-0.7%)
$3.11B(+3.5%)
Sep 1991
-
$790.40M(-2.9%)
$3.00B(+4.0%)
Jun 1991
-
$814.30M(+13.0%)
$2.89B(+4.2%)
Mar 1991
-
$720.50M(+6.3%)
$2.77B(+4.4%)
Dec 1990
$2.65B(+18.6%)
$678.10M(+0.6%)
$2.65B(+5.0%)
Sep 1990
-
$673.80M(-3.3%)
$2.53B(+3.9%)
Jun 1990
-
$696.80M(+15.6%)
$2.43B(-26.8%)
Mar 1990
-
$602.70M(+9.1%)
$3.32B(-22.6%)
Dec 1989
$2.24B(+19.8%)
$552.40M(-4.7%)
$4.29B(+258.1%)
Sep 1989
-
$579.60M(-63.4%)
$1.20B(-42.6%)
Jun 1989
-
$1.59B(+0.9%)
$2.09B(+4.3%)
Mar 1989
-
$1.57B(-161.9%)
$2.00B(+7.2%)
Dec 1988
$1.87B(+36.3%)
-$2.54B(-272.8%)
$1.87B(-11.4%)
Sep 1988
-
$1.47B(-2.1%)
$2.11B(+8.3%)
Jun 1988
-
$1.50B(+4.4%)
$1.95B(+14.8%)
Mar 1988
-
$1.44B(-162.5%)
$1.69B(+23.8%)
Dec 1987
$1.37B(+31.5%)
-$2.30B(-275.9%)
$1.37B(-20.8%)
Sep 1987
-
$1.31B(+4.6%)
$1.73B(+17.1%)
Jun 1987
-
$1.25B(+12.4%)
$1.48B(+19.8%)
Mar 1987
-
$1.11B(-157.3%)
$1.23B(+18.2%)
Dec 1986
$1.04B(+24.0%)
-$1.94B(-284.0%)
$1.04B(-15.4%)
Sep 1986
-
$1.05B(+4.8%)
$1.23B(+19.2%)
Jun 1986
-
$1.00B(+9.1%)
$1.03B(+14.1%)
Mar 1986
-
$921.10M(-152.6%)
$904.60M(+7.7%)
Dec 1985
$839.80M(+5.4%)
-$1.75B(-304.5%)
$839.80M(+6.5%)
Sep 1985
-
$855.80M(-2.5%)
$788.50M(-0.3%)
Jun 1985
-
$877.40M(+2.5%)
$790.60M(-1.7%)
Mar 1985
-
$856.30M(-147.5%)
$804.50M(+1.0%)
Dec 1984
$796.70M
-$1.80B(-309.9%)
$796.80M(-69.3%)
Sep 1984
-
$857.90M(-3.7%)
$2.60B(+49.3%)
Jun 1984
-
$891.30M(+5.0%)
$1.74B(+105.0%)
Mar 1984
-
$848.60M
$848.60M

FAQ

  • What is Merck & Co annual operating income?
  • What is the all time high annual operating profit for Merck & Co?
  • What is Merck & Co annual operating profit year-on-year change?
  • What is Merck & Co quarterly operating income?
  • What is the all time high quarterly operating profit for Merck & Co?
  • What is Merck & Co quarterly operating profit year-on-year change?
  • What is Merck & Co TTM operating income?
  • What is the all time high TTM operating profit for Merck & Co?
  • What is Merck & Co TTM operating profit year-on-year change?

What is Merck & Co annual operating income?

The current annual operating profit of MRK is $20.22B

What is the all time high annual operating profit for Merck & Co?

Merck & Co all-time high annual operating income is $20.22B

What is Merck & Co annual operating profit year-on-year change?

Over the past year, MRK annual operating income has changed by +$17.27B (+584.53%)

What is Merck & Co quarterly operating income?

The current quarterly operating profit of MRK is $4.35B

What is the all time high quarterly operating profit for Merck & Co?

Merck & Co all-time high quarterly operating income is $6.13B

What is Merck & Co quarterly operating profit year-on-year change?

Over the past year, MRK quarterly operating income has changed by +$363.00M (+9.11%)

What is Merck & Co TTM operating income?

The current TTM operating profit of MRK is $20.22B

What is the all time high TTM operating profit for Merck & Co?

Merck & Co all-time high TTM operating income is $20.22B

What is Merck & Co TTM operating profit year-on-year change?

Over the past year, MRK TTM operating income has changed by +$6.06B (+42.80%)
On this page